UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that the Centers for ...

UroGen Pharma (URGN) announced that the Centers for Medicare and Medicaid Services, CMS, has assigned a permanent Healthcare Common Procedure ...

Grower associations celebrated the H-2A revision and called it a major step towards certainty, but are still urging for a permanent solution.

Nigeria has insisted on the implementation of the two state solution to end the Israel-Palestinian crisis. The Permanent ...